Atlantic Life Sciences, Inc.
 


                Frequent Asked Questions - Share yours !
Overview
Volunteer
Internship
Career
Forums
e-Library
Contact
  
31 Selected Regulatory Agencies
Professional associations
Studies due diligence
FAQ - GCPs


 
Receive free updates on this page by E-mail

Subscribe
  


Frequent Asked Question about:
Inspections - Good Clinical Practice [EU] EMEA: Questions and Answers on investigational medicinal products (IMPs) in bioavailability and bioequivalence trials
Pharmacovigilance Inspection Metrics Report [UK] MHRA: Good Pharmacovigilance Practice - Inspection metrics 2009
PI Responsibilities FDA final guidance on "Investigator Responsibilities - Protecting the Rights, Safety, and Welfare of Study Subjects"


Adverse Events		 FDA Guidance for Clinical Investigators, Sponsors, and IRBs. Adverse Event Reporting to IRBs Improving Human Subject Protection
Western IRB Guide for Researchers
Adverse Events Reporting
Health Canada, Industry guidance: Clinical Safety Data Management Definitions and Standards for Expedited Reporting ICH Topic E2A
Orange book, 29th Edition, 2009 Electronic Orange Book - Approved Drug Products with Therapeutic Equivalence Evaluations
What About Drugs and Natural Products? - Drugs A- Z

- Natural Medicines A - Z
Type your question in the window:
Ask
search
ICH website (top/left): Q & A Q8/9/10 - E14 - E2B(M) - E5 - M4 - M4Q - M4S - M4E and M4electronic
 

 

                      Go Back
©2003 - 2010, ALS Inc. All rights reserved